跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gboxin
首页
药物
Gboxin
Gboxin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Preparation method of Gboxin
CN 111518032 A
申请人: WUHAN LUOSHI TECH CO LTD
优先权: 2020
CN
HDAC5激活剂Gboxin在制备促进皮肤创面愈合的药物中的用途
CN 116999434 B
申请人: 上海交通大学医学院附属第九人民医院
优先权: 2023
CN
Prussian blue nano-enzyme capable of regulating and controlling hypoxia and metabolism of tumors and application of Prussian blue nano-enzyme
CN 117771270 A
申请人: UNIV ANHUI MEDICAL
优先权: 2023
CN
SiRNA nano-drug carrier and nano anti-tumor drug
CN 120617294 A
申请人: UNIV HENAN
优先权: 2025
CN
ROS (reactive oxygen species) double-response nanoparticles for co-delivery of metabolic inhibitors and immune activators as well as preparation method and application of ROS double-response nanoparticles
CN 121512966 A
申请人: UNIV FUDAN
优先权: 2025
CN
Pharmaceutical composition combining aquaporin inhibitor and oxidative phosphorylation inhibitor for treating brain glioma and application of pharmaceutical composition
CN 121754535 A
申请人: PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIV SHANDONG PROVINCIAL HOSPITAL
优先权: 2026
CN
药物
反馈